6.
Romagnuolo R, Masoudpour H, Porta-Sanchez A, Qiang B, Barry J, Laskary A
. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias. Stem Cell Reports. 2019; 12(5):967-981.
PMC: 6524945.
DOI: 10.1016/j.stemcr.2019.04.005.
View
7.
Yu Y, Tham S, Roslan F, Shaharuddin B, Yong Y, Guo Z
. Large animal models for cardiac remuscularization studies: A methodological review. Front Cardiovasc Med. 2023; 10:1011880.
PMC: 10050756.
DOI: 10.3389/fcvm.2023.1011880.
View
8.
Karbassi E, Murry C
. Flexing Their Muscles: Maturation of Stem Cell-Derived Cardiomyocytes on Elastomeric Substrates to Enhance Cardiac Repair. Circulation. 2022; 145(18):1427-1430.
PMC: 9069846.
DOI: 10.1161/CIRCULATIONAHA.122.059079.
View
9.
Vicinanza C, Aquila I, Scalise M, Cristiano F, Marino F, Cianflone E
. Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification. Cell Death Differ. 2017; 24(12):2101-2116.
PMC: 5686347.
DOI: 10.1038/cdd.2017.130.
View
10.
Cohen M, Boiangiu C, Abidi M
. Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy. J Am Coll Cardiol. 2010; 55(18):1895-906.
DOI: 10.1016/j.jacc.2009.11.087.
View
11.
Camacho P, Fan H, Liu Z, He J
. Large Mammalian Animal Models of Heart Disease. J Cardiovasc Dev Dis. 2018; 3(4).
PMC: 5715721.
DOI: 10.3390/jcdd3040030.
View
12.
Robey T, Saiget M, Reinecke H, Murry C
. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol. 2008; 45(4):567-81.
PMC: 2587485.
DOI: 10.1016/j.yjmcc.2008.03.009.
View
13.
Azevedo P, Polegato B, Minicucci M, Paiva S, Zornoff L
. Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. Arq Bras Cardiol. 2015; 106(1):62-9.
PMC: 4728597.
DOI: 10.5935/abc.20160005.
View
14.
Kadota S, Tanaka Y, Shiba Y
. Heart regeneration using pluripotent stem cells. J Cardiol. 2020; 76(5):459-463.
DOI: 10.1016/j.jjcc.2020.03.013.
View
15.
Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K
. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep. 2016; 6:19111.
PMC: 4705488.
DOI: 10.1038/srep19111.
View
16.
Sung T, Maitiruze K, Pan J, Gong J, Bai Y, Pan X
. Universal and hypoimmunogenic pluripotent stem cells for clinical usage. Prog Mol Biol Transl Sci. 2023; 199:271-296.
DOI: 10.1016/bs.pmbts.2023.02.014.
View
17.
Garbern J, Lee R
. Heart regeneration: 20 years of progress and renewed optimism. Dev Cell. 2022; 57(4):424-439.
PMC: 8896288.
DOI: 10.1016/j.devcel.2022.01.012.
View
18.
Zhu K, Wu Q, Ni C, Zhang P, Zhong Z, Wu Y
. Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates. Circ Res. 2018; 122(7):958-969.
DOI: 10.1161/CIRCRESAHA.117.311578.
View
19.
Plews J, Gu M, Longaker M, Wu J
. Large animal induced pluripotent stem cells as pre-clinical models for studying human disease. J Cell Mol Med. 2012; 16(6):1196-202.
PMC: 3340484.
DOI: 10.1111/j.1582-4934.2012.01521.x.
View
20.
Cheng Y, Hsieh M, Lin C, Chang C, Huang C, Puntney R
. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates. Circulation. 2023; 148(18):1395-1409.
PMC: 10683868.
DOI: 10.1161/CIRCULATIONAHA.122.061736.
View